Skip to main content
GoodMoatv1.3
Sign in
AMED logo

AMED

CompareEarnings: Nov 30, 2025

Amedisys Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Care Facilities

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.

Did you know?

Net income compounded at -15.6% annually over 6 years.

Current Price

$100.99

+0.01%

GoodMoat Value

$205.64

103.6% undervalued
Profile
Valuation (TTM)
Market Cap$3.31B
P/E38.71
EV—
P/B2.92
Shares Out32.82M
P/Sales1.38
Revenue$2.40B
EV/EBITDA14.14

Amedisys Inc (AMED) Company Profile

AMED Company Information

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services.

Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life.

Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care.

Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company.

With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.

6 million visits annually.

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NASDAQ

Country

Louisiana, USA

AMED Key Officers

Key officers data coming soon

AMED Company Profile

Amedisys Inc (AMED) is a Healthcare company in the Medical Care Facilities industry. It trades on NASDAQ. The company is based in Louisiana, USA.

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.

Market cap is $3.31B. There are 32.8M shares outstanding.

See the full Amedisys Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if AMED is a good investment.